I am an attending physician on the Lymphoma Service in the Department of Medicine. I have had a large clinical practice for more than 30 years, which includes primarily patients with malignant lymphomas, chronic lymphocytic leukemia, and multiple myeloma. I have a longstanding clinical research interest in malignant lymphomas, and have authored more than 150 publications on this topic. I have conducted clinical trials in Hodgkin lymphoma, cutaneous T-cell lymphomas, and HIV-associated lymphomas, as well as studies assessing quality of life and survivorship issues among people with lymphoma.
I chaired a national study of the treatment of patients with early-stage Hodgkin lymphoma for the Cancer and Leukemia Group B (CALGB), and will also be chairing a national trial for the same population of patients for CALGB in collaboration with two other National Cancer Institute-sponsored cancer clinical trials groups: the Southwest Oncology Group and the Eastern Cooperative Oncology Group. In other research projects, I am documenting and attempting to improve the outcome of long-term Hodgkin lymphoma survivors. I am also directing multi-institutional clinical trials evaluating new treatments for elderly patients with aggressive non-Hodgkin lymphoma whose disease relapsed after initial chemotherapy, and in patients with advanced cutaneous T-cell lymphomas.
I have served as a reviewer for many publications in the field of the malignant lymphomas and for a number of grant applications for the National Institutes of Health.